Literature DB >> 6683067

Interactions of morphine with PGE1, isoproterenol, dopamine and aminophylline in rat mast cells; their effect on IgE-mediated 14C-serotonin release.

Y Yamasaki, O Shimamura, A Kizu, M Nakagawa, H Ijichi.   

Abstract

The formaldehyde method was used to examine the interactions of morphine with PGE1, isoproterenol, dopamine and aminophylline in rat mast cells by their effects on IgE-mediated 14C-serotonin release. PGE1 (2 x 10(-8) -2 x 10(-5) M), isoproterenol (10(-10) -10(-8) M), dopamine (4 x 10(-8) -4 x 10(-6) M) and aminophylline (6 x 10(-6) -6 x 10(-4) M) caused dose-related inhibition of the mediator release 1 min after an antigen challenge, and propranolol (10(-7) M) blocked the inhibition by isoproterenol (10(-8) M) but not that by dopamine (4 x 10(-6) M), while haloperidol (4 x 10(-6) M) blocked that by dopamine (4 x 10(-6) M) but not that by isoproterenol (10(-8) M). Morphine (3 x 10(-7) -3 x 10(-5) M) reversed the inhibitory effects of PGE1 (2 x 10(-6) M), isoproterenol (10(-8) M) and dopamine (4 x 10(-6) M) dose-dependently and stereospecifically; naloxone (2 x 10(-4) M) antagonized these reversing actions of morphine (3 x 10(-5) M). Morphine (10(-6) -10(-4) M) did not reverse the inhibitory action of aminophylline (6 x 10(-4) M). These results suggest that the inhibitory responses of mast cells to PGE1, isoproterenol and dopamine but not to aminophylline in immunological mediator release were reversed by morphine through opioid receptors, and that the inhibition of adenylate cyclase in mast cells is one of the biochemical actions of morphine.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6683067     DOI: 10.1007/bf01994277

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  18 in total

1.  Some factors affecting the biological disposition of small doses of morphine in rats.

Authors:  T K ADLER; H W ELLIOTT; R GEORGE
Journal:  J Pharmacol Exp Ther       Date:  1957-08       Impact factor: 4.030

2.  Effects of morphine on dopamine-stimulated adenylate cyclase and on cyclic GMP formation in primate brain amygdaloid nucleus.

Authors:  D Wilkening; R K Mishra; M H Makman
Journal:  Life Sci       Date:  1976-10-15       Impact factor: 5.037

3.  Morphine-like drugs inhibit the stimulation of E prostaglandins of cyclic AMP formation by rat brain homogenate.

Authors:  H O Collier; A C Roy
Journal:  Nature       Date:  1974-03-01       Impact factor: 49.962

4.  Cyclic AMP, ATP, and reversed anaphylactic histamine release from rat mast cells.

Authors:  M Kaliner; K F Austen
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

5.  Immunologic release of histamine and slow reacting substance of anaphylaxis from human lung. V. Effects of prostaglandins on release of histamine.

Authors:  A I Tauber; M Kaliner; D J Stechschulte; K F Austen
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

6.  Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophosphate.

Authors:  R P Orange; W G Austen; K F Austen
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

7.  Characterization of opioid receptors in nervous tissue.

Authors:  H W Kosterlitz; S J Paterson
Journal:  Proc R Soc Lond B Biol Sci       Date:  1980-10-29

8.  Inhibitory role of cyclic adenosine 3' 5'-monophosphate in histamine release from rat peritoneal mast cells in vitro.

Authors:  H Hayashi; A Ichikawa; T Saito; K Tomita
Journal:  Biochem Pharmacol       Date:  1976-08-15       Impact factor: 5.858

9.  Agonist and antagonist actions of morphine-like drugs on the guinea-pig isolated ileum.

Authors:  E A Gyand; H W Kosterlitz
Journal:  Br J Pharmacol Chemother       Date:  1966-09

10.  A neuroblastoma times glioma hybrid cell line with morphine receptors.

Authors:  W A Klee; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

View more
  1 in total

1.  Modulation by alpha 2-adrenergic stimulation of IgE-mediated 14C-serotonin release from rat mast cells.

Authors:  Y Yamasaki; O Shimamura; A Kizu; M Nakagawa; H Ijichi
Journal:  Agents Actions       Date:  1983-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.